Welcome to Myeloma News.com!


My name is Pat Killingsworth, and I have multiple myeloma. I am disabled now, but I still work part-time as a freelance medical writer, covering cancer related conferences and interviewing the brightest myeloma experts from around the world. I try and report on the information I gather from a patient's perspective.

HERE IS HOW IT WORKS: Each story features a short description. Below that you will find a headline. If you would like to read more, simply click-on the headline, and it will take you directly to the source. Quick and easy!

I share my opinions about these and other topics on my daily blog: www.MultipleMyelomaBlog.com.

Good luck and remember: Feel good and keep smiling! Pat

Friday, May 11, 2012

BREAKING NEWS: Results from three new maintenance therapy studies released by Celgene. Does Revlimid significantly increase overall survival numbers when used as maintenance therapy after SCT? Maybe. There will be lots of discussion about this at ASCO next week. I will be in Illinois following the story and reporting the news here and on MultipleMyelomaBlog.com. No doubt that return of active disease is slowed. But what about overall survival?

Lenalidomide Shows Significant Benefit for Myeloma Patients, Phase III Study Suggests

No comments:

Post a Comment